Source: Health Canada shortage reports · Updated Jul 9, 2026
Mupirocin has no current shortage reported in Canada. It has been in shortage before; the history is below.
A topical antibiotic used to treat bacterial skin infections such as impetigo.
Products affected
0 / 2
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
STRAMUCIN
2% · CREAM · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02483459 · ended Apr 23, 2026 · Demand increase for the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Dec 30, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Jul 30, 2025 · Disruption of the manufacture of the drug.
Resolved
STRAMUCIN
2% · CREAM · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02483459 · ended Apr 30, 2025 · Demand increase for the drug.
Resolved
STRAMUCIN
2% · CREAM · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02483459 · ended Mar 12, 2025 · Shortage of an inactive ingredient or component.
Resolved
STRAMUCIN
2% · CREAM · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02483459 · ended Mar 12, 2025 · Demand increase for the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Aug 5, 2022 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Aug 23, 2019 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Aug 16, 2019 · Disruption of the manufacture of the drug.
Resolved
TARO-MUPIROCIN
2% · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02279983 · ended Jul 19, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Mupirocin. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Mupirocin is classified under “ANTIBIOTICS FOR TOPICAL USE” (ATC D06AX).
Recent changes
No changes recorded yet.
Common questions
What is Mupirocin used for?
A topical antibiotic used to treat bacterial skin infections such as impetigo.
When will Mupirocin be back in stock in Canada?
Mupirocin has no active shortage; supply is normal per Health Canada reports.
Why is Mupirocin in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.